comparemela.com

Page 4 - Adverum Biotechnologies Daily News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Comparing Adverum Biotechnologies (NASDAQ:ADVM) & bluebird bio (NASDAQ:BLUE)

Comparing Adverum Biotechnologies (NASDAQ:ADVM) & bluebird bio (NASDAQ:BLUE)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Commodore Capital LP Grows Stock Position in Adverum Biotechnologies, Inc (NASDAQ:ADVM)

Commodore Capital LP grew its holdings in shares of Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Free Report) by 100.0% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 10,000,000 shares of the biotechnology company’s stock after purchasing an additional 5,000,000 shares during the quarter. Adverum […]

Adverum Biotechnologies, Inc (NASDAQ:ADVM) Stock Position Trimmed by BML Capital Management LLC

BML Capital Management LLC reduced its stake in shares of Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Free Report) by 27.0% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 5,157,179 shares of the biotechnology company’s stock after selling 1,910,000 shares during the period. Adverum Biotechnologies makes up […]

Commodore Capital LP Makes New Investment in Adverum Biotechnologies, Inc (NASDAQ:ADVM)

Commodore Capital LP acquired a new position in shares of Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 5,000,000 shares of the biotechnology company’s stock, valued at approximately $3,587,000. Adverum Biotechnologies accounts for 0.5% […]

Adverum Biotechnologies (NASDAQ:ADVM) Stock Rating Reaffirmed by Truist Financial

Truist Financial restated their buy rating on shares of Adverum Biotechnologies (NASDAQ:ADVM – Free Report) in a research report released on Tuesday, Benzinga reports. They currently have a $6.00 price target on the biotechnology company’s stock. Other equities analysts have also issued research reports about the stock. StockNews.com initiated coverage on shares of Adverum Biotechnologies […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.